20 February 2006
P2i targets biotech sector with ion-mask™ enhancement
Revolutionary cold plasma enhancement maximises sample recovery and reduces reagent loss
Oxford, UK P2i Ltd, the nanoscale enhancer of products using its proprietary cold plasma ion-mask™ process, is setting its sights on the pharmaceutical and biotech sectors. Initial trials on a range of laboratory consumables from pipette tips, to microplates and disposables have produced dramatic results, improving sample recovery and enhancing the non-binding properties of the surfaces.
“Laboratory work, especially in medical and forensic diagnostics, calls for the analysis of minute samples”, explains P2i’s Technical Director, Dr Stephen Coulson. “Residual retention not only affects the accuracy of test results but, with many reagents being extremely costly, there are economic implications as well. In tests, pipette tips enhanced with ion-mask™ proved more accurate and reliable with reagent wastage costs reduced by up to 10 percent.”
“We are discovering new applications for ion-mask™ enhancement by the day and are already in discussion with a number of leading names in the biotech sector who are keen to see how ion mask™ can improve their products,” adds Dr Coulson.